Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4512)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (169)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (179)
½Å¾à°³¹ß (1306)
¾ÏÄ¡·á (856)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (105)
Á¤½ÅÁúȯ (88)
Á¦³×¸¯ ÀǾàǰ (116)
Á¦¾àȸ»çºÐ¼® (488)
󹿾à (128)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

´ç´¢º´ ½ÃÀåÁ¶»çº¸°í¼­

´ç´¢º´ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 158 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
»ùÇÃ
»óǰÄÚµå :227854
¼¼°èÀÇ Àν¶¸° Àü´Þ ±â±â(Insulin Delivery Devices) ½ÃÀå ÁÖ¿ä µ¥ÀÌÅÍ, Á¤º¸ ¹× ºÐ¼®À» Á¦°øÇϰí, ½ÃÀå ±¸µµ, °æÀï ±¸µµ, ½ÃÀå µ¿Çâ, ½ÃÀå ¿ªÇÐ, ±â¼ú µ¿Çâ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,995
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 104
Global Diabetes Devices Market 2010-2014
»ùÇÃ
»óǰÄÚµå :229548
¼¼°èÀÇ ´ç´¢º´ °ü·Ã ±â±â(Diabetes Devices) ½ÃÀå¿¡ ´ëÇÑ 2010-2014³â°£ ºÐ¼®À» ½Ç½ÃÇϰí, ½ÃÀå±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¼ºÀå ¿äÀΰú °úÁ¦, ÁÖ¿ä º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Infiniti Research Limited
ÆäÀÌÁö¼ö Pages: 33
»ùÇÃ
»óǰÄÚµå :206637
¾Æ¸£ÇîÆ¼³ªÀÇ ´ç´¢º´ °ü¸®±â±â(Diabetes Management Devices) ½ÃÀå°ú Á¦Ç° Ä«Å×°í¸®¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð, Æò±Õ ÆÇ¸Å°¡°Ý, ¼ºÀå µ¿Çâ, °¢ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© 2016³â±îÁöÀÇ ¿¹Ãø°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Ace Business and Market Research Group (ABMRG)
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :206636
º§±â¿¡ÀÇ ´ç´¢º´ °ü¸®±â±â(Diabetes Management Devices) ½ÃÀå°ú Á¦Ç° Ä«Å×°í¸®¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð, Æò±Õ ÆÇ¸Å°¡°Ý, ¼ºÀå µ¿Çâ, °¢ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© 2016³â±îÁöÀÇ ¿¹Ãø°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Ace Business and Market Research Group (ABMRG)
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :206634
À̽º¶ó¿¤ÀÇ ´ç´¢º´ °ü¸®±â±â(Diabetes Management Devices) ½ÃÀå°ú Á¦Ç° Ä«Å×°í¸®¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð, Æò±Õ ÆÇ¸Å°¡°Ý, ¼ºÀå µ¿Çâ, °¢ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© 2016³â±îÁöÀÇ ¿¹Ãø°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Ace Business and Market Research Group (ABMRG)
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :206632
³×´ú¶õµåÀÇ ´ç´¢º´ °ü¸®±â±â(Diabetes Management Devices) ½ÃÀå°ú Á¦Ç° Ä«Å×°í¸®¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð, Æò±Õ ÆÇ¸Å°¡°Ý, ¼ºÀå µ¿Çâ, °¢ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© 2016³â±îÁöÀÇ ¿¹Ãø°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Ace Business and Market Research Group (ABMRG)
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :206630
³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÇ ´ç´¢º´ °ü¸®±â±â(Diabetes Management Devices) ½ÃÀå°ú Á¦Ç° Ä«Å×°í¸®¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð, Æò±Õ ÆÇ¸Å°¡°Ý, ¼ºÀå µ¿Çâ, °¢ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© 2016³â±îÁöÀÇ ¿¹Ãø°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Ace Business and Market Research Group (ABMRG)
ÆäÀÌÁö¼ö  
Global Diabetes Market Report: 2011 Edition
»ùÇÃ
»óǰÄÚµå :223069
¼¼°è °¢±¹ÀÇ ´ç´¢º´(Diabetes) °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, ¼¼°èÀûÀÎ ±â¼ú ¹× ½ÃÀå µ¿Çâ, °¢ Áö¿ª ½ÃÀå µ¿Çâ, ÃֽнÃÀå µ¿Çâ, ÃËÁø¿äÀÎ, °úÁ¦, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ °³¿ä, ÇâÈÄ ½ÃÀå µ¿Çâ ¿¹Ãø µîÀÇ ³»¿ëÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 800
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Koncept Analytics
ÆäÀÌÁö¼ö 58 Pages
Global Diabetes Devices & Drugs Market (2011- 2016)
»ùÇÃ
»óǰÄÚµå :223415
¼¼°èÀÇ ´ç´¢º´(Diabetes) ½ÃÀåÀ» Á¶»çÇϰí, 2016³â±îÁöÀÇ ½ÃÀå±Ô¸ð¿Í ¿¹Ãø, Áö¿ªº° µ¿Çâ, ¾÷°è³» ÇÕº´°ú Àμö µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,395
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Transparency Market Research
ÆäÀÌÁö¼ö 122 Pages
Hyperglycemia Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :217847
¼¼°è °¢±¹ÀÇ °íÇ÷´çÁõ(Hyperglycemia) ÀÓ»ó½ÃÇè¿¡ ´ëÇØ Á¶»çÇϰí, Áö¿ª, ÁøÇà »óȲ, ´Ü°è(»ó), ¸ðÁý »óȲº° ½Ç½Ã °Ç¼ö, ´ëÇ¥ÀûÀÎ ½ºÆù¼­, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸, °¢ ±â¾÷ ¹× ±â°ü¿¡¼­ÀÇ ÁøÇà »óȲ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 90
Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018
»ùÇÃ
»óǰÄÚµå :217228
1Çü ´ç´¢º´ÀÇ °³¿ä¿Í Áø´Ü, Ä¡·á¹ý, Ä¡·áÁ¦ ½ÃÀåÀÇ ±Ô¸ð¿Í 2018³â±îÁöÀÇ ¿¹Ãø, ÁÖ¿ä ½ÃÀ庰 µ¿Çâ, °³¹ß ÆÄÀÌÇÁ¶óÀÎ, Âü¿©±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 102
»ùÇÃ
»óǰÄÚµå :217230
´ç´¢º´¼º ½ÅÀå Áúȯ(Diabetic Nephropathy) Ä¡·áÁ¦ ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ µ¥ÀÌÅ͸¦ Á¶»çÇϰí, ±¹°¡º° µ¿Çâ, ÀÓ»ó½ÃÇè ¼ö, ¼¼°èÀÇ ÀÓ»ó½ÃÇè¼Òº° ¸ðÁý »óȲ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 99
Glucose Intolerance Global Clinical Trials Review, H2, 2011
»ùÇÃ
»óǰÄÚµå :217229
¼¼°èÀÇ 2011³â ÇϹݱ⠳»´ç´É Àå¾Ö¿¡ °üÇÑ ÀÓ»ó½ÃÇè µ¿Çâ¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Áö¿ªº°, ´Ü°èº° ºÐ¼®, °³¹ß ÁßÀÎ ¾àÁ¦ °³¿ä, 1982³âºÎÅÍ 2011³â 9¿ù±îÁöÀÇ µî·Ï ¾àÁ¦ 70°³¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 78
European Diabetes Therapeutics Market
»ùÇÃ
»óǰÄÚµå :213208
À¯·´ÀÇ ´ç´¢º´ Ä¡·áÁ¦(Diabetes Therapeutics) ½ÃÀåÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®Çϰí, À¯·´ °¢±¹ ½ÃÀå ¹× ±â¼ú µ¿Çâ, Àν¶¸°°ú °æ±¸ Ç×´ç´¢º´Á¦ 2°³¸¦ Áß½ÉÀ¸·Î ÇÑ Á¦Ç° °³¿ä, °¢±¹ÀÇ ±ÔÁ¦ µ¿Çâ, »õ·Î¿î Ä¡·á¹ý µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,500
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 151 Pages
Global Blood Glucose Test Strips Market 2010-2014
»ùÇÃ
»óǰÄÚµå :213156
¼¼°èÀÇ Ç÷´ç ½ÃÇèÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2010³â-2014³â), ½ÃÀå µ¿Çâ ¹× °úÁ¦, º¥´õ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Infiniti Research Limited
ÆäÀÌÁö¼ö 30 Pages
DPP IV Inhibitors
»ùÇÃ
»óǰÄÚµå :222501
¼¼°èÀÇ DPP IV ÀúÇØÁ¦(DPP IV Inhibitors) ½ÃÀå ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, DPP IV ÀúÇØÁ¦ÀÇ ±â¼­, ´ç´¢º´ Ä¡·á¿¡¼­ÀÇ À¯È¿¼º, ÁÖ¿ä Ãâ½ÃÁ¦Ç°ÀÇ Æ÷Áö¼Å´×, ÁÖ¿ä ½ÂÀÎ ¾àÁ¦ ¸®ºä¿Í ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®, ÁÖ¿ä Áö¿ª ¹× ±¹°¡ ½ÃÀåÀÇ ÁÖ¿ä µ¿Çâ, ½ÃÀå ±Ô¸ð ½ÇÀû ¹× ¿¹Ãø(¡­2017³â), Èí¼öÇÕº´ ¹× Á¦ÈÞ °è¾à µî ±â¾÷°£ÀÇ µ¿Çâ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,200
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 363
»ùÇÃ
»óǰÄÚµå :226821
2Çü ´ç´¢º´ Ä¡·áÁ¦ ³ëº¸·Î±×(Novolog)¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, 2Çü ´ç´¢º´ ½ÃÀåÀÇ Æ¯Â¡, ´ç´¢º´ÀÇ ºÐ·ù, Ç×´ç´¢º´ Ä¡·áÀÇ ÁøÈ­, Åõ¾à Ä¡·á °³¿ä, NovologÀÇ ÀÓ»ó ¿¬±¸, ½ÂÀÎ ÀÌ·Â, ÆÇ¸Å ¿µÇâ¿äÀÎ, ÀǾàǰ Æò°¡, ÆÇ¸Å ¿¹Ãø µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 42
»ùÇÃ
»óǰÄÚµå :209511
¹Ì±¹ 2Çü ´ç´¢º´ ȯÀÚÀÇ ÆæÇü ÁÖ»ç±â(Injection Pens) »ç¿ë µ¿ÇâÀ» Á¶»ç ºÐ¼®Çϰí, ºê·£µåº° µ¿Çâ, ÀÎÁ§¼Ç ÆæÀÇ Æ¯Â¡°ú Ư¼º, ºê·£µåº° ¸¸Á·µµ, ÇâÈÄ »ç¿ë Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 10,000
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 66 Pages
Hot Topics in Type 2 Diabetes: Complications and Comorbidities - Physician insight on diabetic complications, comorbidities and treatment
»ùÇÃ
»óǰÄÚµå :210000
±¹°¡º° 2Çü ´ç´¢º´(Type 2 Diabetes) ȯÀÚÀÇ ÇÕº´Áõ°ú µ¿¹ÝÁúȯ¿¡ ´ëÇÑ ÀÇ»ç °ßÇØ¸¦ ºÐ¼®Çϰí, ȯÀÚ Ä¡·á ±âȸ, ¿ÀÇǴϾ𠸮´õÀÇ °ßÇØ, Ä¡·á ¼±ÅÃÀÌ ºñ¸¸ ¹× ½ÅºÎÀü µîÀÇ Áúȯ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´ÂÁö µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,700
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 55
Hot Topics: Obesity - The US FDA and cardiovascular risk analysis: the AdComm Cometh
»ùÇÃ
»óǰÄÚµå :208187
´ç´¢º´¾à(Diabetes Drug)ÀÇ ½ÉÀåÇ÷°ü ¾ÈÀü¼º°ú ÇâÈÄÀÇ ºñ¸¸(Obesity) ½ÃÀå°úÀÇ °ü·Ã¼º¿¡ ´ëÇØ ºÐ¼®Çϰí, Àå±âÀû °íÂûÀÌ ÇÊ¿äÇÑ °úÁ¦, ½Å±Ô °¡À̵å¶óÀÎÀÇ ½ÇÇà¿¡ °ü·ÃµÈ ÀÓ»óÀû, »ó¾÷Àû ¿µÇ⠵ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,800
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 30
71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis
»ùÇÃ
»óǰÄÚµå :205769
2011³â 6¿ù¿¡ °³ÃÖµÈ Á¦71ȸ ¹Ì±¹´ç´¢º´ÇÐȸ ¿¬Â÷ Çмú´ëȸ(American Diabetes Association 71st Scientific Sessions)ÀÇ ÇÏÀ̶óÀÌÆ®¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 32
»ùÇÃ
»óǰÄÚµå :206502
Á¶»ç Áý°è Á¤º¸¸¦ Á¤¸®ÇßÀ¸¸ç, ÁÖ¿ä ¿ÀÇǴϾ𠸮´õÀÇ °íÂûÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,700
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 62
Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2011-2021
»ùÇÃ
»óǰÄÚµå :209075
¼¼°èÀÇ ³ëÀμº Ȳ¹Ýº¯¼º(AMD) ¹× ´ç´¢¸Á¸·º´Áõ(DR) ½ÃÀåÀÇ 2021³â±îÁöÀÇ ¸ÅÃâ ¿¹Ãø, ÁÖ·Â Á¦Ç°, À¯·´ ¹× ¹ÌÁÖ, Áß±¹, Àεµ, ÀϺ» µîÀÇ Áö¿ªº° µ¿Çâ, ÁÖ¿ä ±â¾÷ °³¿ä µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,331
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 204 Pages
R&D Trends: Non-Insulin Antidiabetics - What opportunities remain for the vast pipeline in the crowded diabetes market?
»ùÇÃ
»óǰÄÚµå :206522
1Çü, 2Çü ´ç´¢º´À» Æ÷ÇÔÇÑ ÇöÀçÀÇ ºñÀν¶¸° ´ç´¢º´Ä¡·áÁ¦ ÆÄÀÌÇÁ¶óÀο¡ ´ëÇØ Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ´Ù¾çÇÑ Ä¡·á¹ý¿¡¼­ ¼º°øÇϱâ À§ÇØ ÇÊ¿äÇÑ Á¦Ç° °³¿ä, ÀÓ»ó½ÃÇè µðÀÚÀΰú µ¿Çâ, ÇâÈÄ ¹æÇ⼺ µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,800
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 76
China Diabetes Market Analysis
»ùÇÃ
»óǰÄÚµå :203986
Áß±¹ÀÇ ´ç´¢º´(Diabetes) °ü·Ã ½ÃÀå¿¡ ´ëÇØ Á¶»çÇϰí, ´ç´¢º´ÀÇ ¸¸¿¬, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ¿äÀÎ, °ü·Ã ¾àǰ ¹× ±â±â ½ÃÀåÀÇ Ãֽе¿Çâ, Á¤ºÎÀÇ Á¤Ã¥, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 800
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 50 Pages